Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 27 entries
View as:

Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04921566 Org: User:
Start: 06/05/21 End: 06/20/21 Due: 06/20/22

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03459911 Org: User:
Start: 02/16/18 End: 03/16/18 Due: 03/16/19

The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04012307 Org: User:
Start: 07/11/19 End: 08/14/19 Due: 08/14/20

Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05934799 Org: User:
Start: 06/16/23 End: 10/10/23 Due: 10/10/24

Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05061901 Org: User:
Start: 10/06/21 End: 11/06/21 Due: 11/06/22

Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04038008 Org: User:
Start: 07/26/19 End: 01/13/20 Due: 01/13/21

The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT03951051 Org: User:
Start: 05/06/19 End: 06/16/19 Due: 06/16/20

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

Phase: N/A Priority: Normal
NCT ID: NCT03705533 Org: User:
Start: 09/07/18 End: 12/19/18 Due: 12/19/19

Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05438316 Org: User:
Start: 06/17/22 End: 11/17/22 Due: 11/17/23

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04753489 Org: User:
Start: 02/13/21 End: 03/01/21 Due: 03/01/22

Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03918551 Org: User:
Start: 05/03/19 End: 06/06/19 Due: 06/06/20

Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06213610 Org: User:
Start: 01/09/24 End: 06/01/24 Due: 06/01/25

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04882826 Org: User:
Start: 05/10/21 End: 05/30/21 Due: 05/30/22

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03898193 Org: User:
Start: 03/23/19 End: 04/08/19 Due: 04/08/20

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05642845 Org: User:
Start: 11/19/22 End: 06/05/23 Due: 06/05/24

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03616301 Org: User:
Start: 07/28/18 End: 08/13/18 Due: 08/13/19

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05685277 Org: User:
Start: 12/28/22 End: 07/31/23 Due: 07/31/24

Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03799536 Org: User:
Start: 01/09/19 End: 02/11/19 Due: 02/11/20

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03702894 Org: User:
Start: 09/21/18 End: 10/08/18 Due: 10/08/19

Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05940909 Org: User:
Start: 06/24/23 End: 11/17/23 Due: 11/17/24

Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03915340 Org: User:
Start: 03/23/19 End: 05/08/19 Due: 05/08/20

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04729998 Org: User:
Start: 01/30/21 End: 02/15/21 Due: 02/15/22

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04138888 Org: User:
Start: 10/31/19 End: 12/24/19 Due: 12/24/20

Bioequivalence Study of Ibuprofen D, Oral Suspension, 200 mg/5ml and Nurofen®, Oral Suspension 100 mg/5 ml in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03561558 Org: User:
Start: 06/11/18 End: 06/25/18 Due: 06/25/19

Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05339373 Org: User:
Start: 04/15/22 End: 08/15/22 Due: 08/15/23